Bone and Joint Infections

exp date isn't null, but text field is

Acute Osteomyelitis

Infection of the bone with symptoms for <14 days

Staphylococcus aureus is the most common pathogen.

Antimicrobial 

Cloxacillin 2g (child 50mg/kg) IV QID

Alternative:

Cefazolin 2g (child 50mg/kg) IV TID

OR

Clindamycin 600mg (child 15mg/kg) IV TID

OR

Vancomycin IV, dose according to Vancomycin dosing section

Change to oral antibiotics when appropriate (see comments). If susceptibility results are not available use:

Cloxacillin 1g (child 25mg/kg) PO QID

Comments and Duration of Therapy

Take blood cultures prior to antibiotics.

Acute osteomyelitis is potentially curable with antibiotics alone. In adults who respond to treatment rapidly an early IV to PO switch can be considered if susceptibilities are known, and antibiotics with good oral bioavailability are used (e.g. clindamycin, co-trimoxazole, ciprofloxacin). Adults with an associated Staphylococcus aureus bacteraemia should receive at least 4 weeks IV therapy (see Staphylococcus bacteraemia in Sepsis and Directed Therapy for Blood Stream Infections).

Duration:

Adults: Treat for a total of 6 weeks, with a minimum of 2-4 weeks IV.

Children:

Uncomplicated: Treat for at least 3 weeks, with a minimum of 3 days IV.

Complicated (non-long bone, associated abscess, delayed presentation, slow clinical improvement): Treat as per adult.

Chronic Osteomyelitis

Infection of bone with symptoms over months to years. Cortical destruction with sequestrum (necrotic bone) and involucrum (new bone) may be present. The presence of a sinus tract is pathognomonic for chronic osteomyelitis.

Consider Tuberculosis as a potential pathogen.

Antimicrobial 

Unless septic do not give antibiotics until after bone has been debrided and culture results are available. Use directed treatment wherever possible.

Cloxacillin 2g (child 50mg/kg) IV QID.

Alternative:

Cefazolin 2g (child 50mg/kg) IV TID

OR

Clindamycin 600mg (child 15mg/kg) IV TID

OR

Vancomycin IV dose according to Vancomycin dosing section

Followed by:

Cloxacillin 1g (child 25mg/kg) PO QID

Comments and Duration of Therapy 

Send tissue and deep sinus tract swab for cultures. Send blood cultures if systemically unwell. Change antibiotics according to culture results.

Aggressive debridement of necrotic bone is important to achieve cure.

Patients on long-term antibiotic therapy should have CBC, and liver and renal function monitored regularly.

Duration:

Adults: Change to oral antibiotics after 2 weeks IV. Treat for a total of 3 months. Longer therapy may be required if inflammatory markers (ESR, CRP) do not normalize.

Children: Change to oral antibiotics when well. Treat for a minimum of 6 weeks.

Infected fracture fixation device

Management of infected hardware is complicated by the formation of biofilm on foreign material. Many antibiotics do not achieve high enough concentrations within biofilms to cure infection. Often hardware removal is required to achieve cure, however this must be balanced against the importance of fracture stability for union and for the treatment of infection.

Where hardware cannot be removed seek review by Infectious Diseases if available.

Antimicrobial 

Unless septic do not give antibiotics (except surgical prophylaxis) until after bone has been debrided and sent for culture. Commence empiric treatment after debridement, or after blood cultures if septic.

Cloxacillin 2g (child 50mg/kg) IV QID

Alternative:

Cefazolin 2g (child 50mg/kg) IV TID

OR

Clindamycin 600mg (child 15mg/kg) IV TID

OR

Vancomycin IV, dose according to Vancomycin dosing section

In the case of Staphylococcus aureus infection with retention of hardware, after thorough debridement and a course of IV antibiotics consider the use of biofilm active agents:

Rifampicin 300mg PO BID

PLUS

Ciprofloxacin 500mg PO BID

Do not use either of these agents alone, and ensure there are no symptoms of TB before commencing rifampicin.

Comments and Duration of Therapy

Send tissue and deep sinus tract swab for cultures. Send blood cultures if systemically unwell.

Where hardware is no longer required for bone stability, it should be removed and necrotic bone and tissue thoroughly debrided.

Where hardware must be retained for fracture nonunion, continue antibiotics until fracture union is achieved, then remove hardware.

Cure of infection with retention of hardware is more likely to be achieved if infection has occurred within 3 weeks of hardware insertion.

Duration:

With removal of hardware: Treat for 2-6 weeks IV, then change to oral antibiotics. Continue antibiotics for 6 weeks after removal of hardware.

Without removal of hardware: If hardware cannot be removed continue antibiotics for 12 weeks and consider ongoing long-term suppression after this.

See Open Fracture prophylaxis in Antibiotic Prophylaxis.

Septic Arthritis

Usually presents as a monoarticular arthritis, spontaneously or following trauma. It can also occur in the setting of multifocal Staphylococcus aureus disease. If relevant see Staphylococcus bacteraemia in Sepsis and Directed Therapy for Blood Stream InfectionsSurgical washout is required. Send joint fluid for microscopy, culture and susceptibility testing.

Antimicrobial

Cloxacillin 2g (child 50mg/kg) IV QID

Alternative:

Cefazolin 2g (child 50mg/kg) IV TID

OR

Clindamycin 600mg (child 15mg/kg) IV TID

OR

Vancomycin IV, dose according to Vancomycin dosing section

In neonates, Group B Streptococcus and Haemophilus influenzae are common pathogens, ADD:

Ampicillin 50mg/kg IV QID

If Neisseria gonorrhoea is confirmed change to:

Ceftriaxone 2g (child: 50mg/kg) IV OD

Comments and Duration of Therapy

Send blood cultures prior to commencement of antibiotics. Unless patient is septic send synovial fluid for culture prior to commencement of antibiotics.

Exclude acute rheumatic fever in young patients.

Consider Gonococcal arthritis in patient with risk factors. Send urine and synovial fluid for gonococcal PCR, and send urethral, vaginal, or rectal swabs for PCR and culture.

Send synovial fluid for TB PCR if consistent clinical picture.

If no response to empiric treatment and no microbiological diagnosis, seek Infectious Diseases review.

Duration:

Adults: Treat for a total of 4 weeks, with a minimum of 2 weeks IV. Use antibiotics with good oral bioavailability (see below) if changing to oral antibiotics at 2 weeks.

Children: Treat for a total of 2-3 weeks. If rapid clinical response change to oral antibiotics after 5-7 days.

Neisseria gonorrhoeae: Treat for 10-14 days, longer if slow response or immunocompromised.

Antibiotics with good oral bioavailability include:

  • Fluoroquinolones
  • Co-trimoxazole
  • Clindamycin
  • Doxycycline
  • Metronidazole
  • Azithromycin

In adults do not use ciprofloxacin alone to treat a Staphylococcus aureus infection.

Prosthetic Joint Infection (PJI)

Management of infected hardware is complicated by the formation of biofilm on foreign material. Many antibiotics do not achieve high enough concentrations within biofilms to cure infection. Extensive debridement with or without hardware removal are required to cure PJI. In some cases cure cannot be achieved and long-term antibiotic suppression is required.

Surgical options for treatment of PJI include one and two-stage exchange arthroplasty, debridement and retention of prosthesis (DAIR), excision arthroplasty and implant retention without curative intent. Two-stage arthroplasty has the highest cure rates (85-95%).

Seek review by Infectious Diseases if available.

Antimicrobial 

Unless septic do not give antibiotics until after synovial fluid, tissue and/or hardware have been debrided and sent for culture. Send at least 3-6 tissue samples and synovial fluid for culture. Use new, fresh, sterile surgical instruments for each collection to avoid cross-contamination. If septic take 2 sets of blood cultures prior to antibiotics.

For empiric treatment while awaiting culture results use:

Vancomycin IV, dose according to Vancomycin dosing section

Once culture results are available change to directed therapy.

For two-stage exchange arthroplasty:

After removal of infected prosthesis and insertion of spacer, treat with at least 6 weeks of antibiotics. Stop antibiotics for 7-14 days prior to second operation. Take intraoperative cultures (3-6 samples) from bone/synovium/fluid at second operation then restart antibiotics. If cultures are positive from second operation treat for a further 6 weeks. If cultures are negative stop antibiotics.

For one-stage exchange arthroplasty:

After joint exchange treat with IV antibiotics for 2-6 weeks. After this for Staphylococcus aureus PJI treat with rifampicin 300mg BID PLUS ciprofloxacin 500mg BID. For gram negative PJI treat with ciprofloxacin 500mg BID if susceptible. If treating with 6 weeks of IV antibiotics consider adding rifampicin 300mg BID once bacteraemia has cleared. Treat for a total of 6-12 weeks.

For DAIR:

Following debridement and replacement of exchangeable components treat with 2-6 weeks of directed IV antibiotics. After this for Staphylococcus aureus PJI treat with rifampicin 300mg BID PLUS ciprofloxacin 500mg BID. For gram negative PJI treat with ciprofloxacin 500mg BID if susceptible. If treating with 6 weeks of IV antibiotics consider adding rifampicin 300mg BID once bacteraemia has cleared. Treat for a total of 3-6 months.

For resection arthroplasty:

Treat with 2-6 weeks of IV antibiotics. Change to oral antibiotics with good oral bioavailability. Treat for 6-12 weeks total.

For implant retention without curative intent:

Treat with IV antibiotics until patient is clinically improving. Change to oral antibiotics according to susceptibilities. Chose antibiotics which are well tolerated; biofilm activity is not necessary. Continue treatment lifelong.

Comments and Duration of Therapy 

Consider DAIR in patients with all of the following:

  • No sinus tract
  • < 30 days since joint replacement OR < 3 weeks of symptoms
  • Well-fixed arthroplasty
  • Good soft tissue condition
  • No associated sepsis
  • Monomicrobial infection (only a single organism cultured)
  • Infection with bacteria which are sensitive to antibiotics with good oral bioavailability and biofilm activity
  • Absence of multiple comorbidities or immune compromise.

In patients who meet these conditions eradication of infection is possible in up to 70% of patients.

Antibiotics with good oral bioavailability include:

  • Fluoroquinolones
  • Rifampicin
  • Co-trimoxazole
  • Clindamycin
  • Doxycycline
  • Metronidazole
  • Azithromycin

Do not use rifampicin alone and ensure there are no symptoms of TB before commencing this. Do not use ciprofloxacin alone to treat a Staphylococcus aureus infection.

Antibiotics with biofilm activity include:

  • Fluoroquinolones
  • Rifampicin
References

Bernard L, Arvieux C, Brunschweiler B, Touchais S, Ansert S, Bru J-P, et al. Antibiotic therapy for 6 or 12 weeks for prosthetic joint infection. NEJM 2021; 384:1001-2001. DOI: 10.1056/NEJMoa2020198

Depypere M, Morgenstern M, Kuehl R, Senneville E, Moriarty T, Obremskey W, et al. Narrative review: Pathogenesis and management of fracture-related infection. Clin Microbiol Infect 2020; 26: 572-578. DOI: https://doi.org/10.1016/j.cmi.2019.08.006

eTG complete. Bone and Joint Infections. In: Therapeutic Guidelines [digital]. Melbourne: Therapeutic Guidelines Limited; 2019. http://www.tg.org.au

Fantoni M, Taccari F, Giovannenze F. Systemic antibiotic treatment of chronic osteomyelitis in adults. Eur Rev Med Pharmacol Sci 2019; 23 (2 Suppl):258-270. doi: 10.26355/eurrev_201904_17500

Gusmao dos Santos C, Francis J, Guterres J, Janson S, Lopes N, Marr I, et al. HNGV Antibiotic guidelines writing group. Antibiotic guidelines Hospital Nacional Guideo Valadares. Timor-Leste; 2016

Li H-K, Rombach I, Zambellas R, Walker A, McNally M, Atkins B, et al. Oral versus intravenous antibiotics for bone and joint infection. NEJM 2019; 380:425-436. DOI: 10.1056/NEJMoa1710926

Malaysian antimicrobial guideline technical working group. National antimicrobial guideline. Ministry of Health Malaysia; 2019

Metsemakers W, Morgenstern M, Senneville E, Borens O, Govaert G, Onsea J, et al. General treatment principles for fracture-related infection: recommendations from an international expert group. Arch Orthop Trauma Surg 2020; 140: 1013-1027. DOI: https://doi.org/10.1007/s00402-019-03287-4

Nanchahal J, Nayagam S, Khan U, Moran C, Barrett S, Sanderson F et al. Standards for the management of open fractures of the lower limb. British Association of Plastic Reconstructive and Aesthetic Surgeons, British Orthopaedic Association. London: Royal Society of Medicine Press Limited; 2009

Osmon D, Berbari E, Berendt A, Lew D, Zimmerli W, Steckelberf J, et al. Diagnosis and management of prosthetic joint infections: clinical practice guidelines by the Infectious Diseases Society of America. Clin Infect Dis 2013; 56(1):e1-25. DOI: 10.1093/cid/cis803